VELCADE (bortezomib) indgives som en intravenøs bolusinjektion kombineret med oral melphalan og oral prednison i ni 6- ugers behandlingscyklusser som vist i tabel 2.
Posology for combination therapy VELCADE (bortezomib) is administered in combination with oral melphalan and oral prednisone for nine 6-week treatment cycles as shown in Table 2.